Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Nevada Hepatitis C Doctor Ruled Competent for TrialOutpatientSurgery.netThe latest twist in a case full of them finds a Las Vegas doctor accused of exposing patients to hepatitis C ruled competent to stand trial. Despite initially being found incompetent due to the effects of 2 strokes suffered in recent years, ...See all stories on this topic »

Inmates 'denied' hepatitis care: LibsThe Canberra TimesBY HENRIETTA COOK ACT prisoners face inadequate health care with one-third of hepatitis C-infected inmates waiting for treatment, according to the Canberra Liberals. On August 22, there were 33 prisoners in the Maconochie Centre waiting for ...See all stories on this topic »

Compass Biotechnologies, Inc. Seeking Drugs to Fight and Prevent HCV InfectionSacramento Bee"The Hepatitis C Vaccine market potential for Compass is approximately US$2 billion, but with the development of a second anti HCV type product based on new scientific findings that augments to make a HCV vaccine even more potent, then this means that ...See all stories on this topic »

I-Team: Doctors Believe Man at the Center of Hep C Outbreak Faking IllnessKLAS-TVBy Colleen McCarty, Investigative Reporter - bio | email By Zuelke, Photojournalist - email LAS VEGAS -- Late last week, state medical experts determined Dr. Depak Desai, the man at the center of the 2007 hepatitis C outbreak, was competent to ...See all stories on this topic »

Surgeons Question New Transplant GuidelinesPhysician's Weekly Blog (blog)Between 2007 and 2010, the CDC found more than 200 cases of suspected HIV, hepatitis B and hepatitis C transmission through transplants; some of the cases resulted in the deaths of the organ recipients. More disturbingly, the CDC also discovered that ...See all stories on this topic »

Physician's Weekly Blog (blog)

Enanta's Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of ...PR Newswire (press release)26, 2011 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today that its lead development candidate from its NS5A hepatitis C virus (HCV) inhibitor program, EDP-239, has been recognized on Windhover's list of the "Top 10 Most Interesting

....See all stories on this topic »

Research Yields Unprecedented Insight into Antiviral Immune ResponseNewswise (press release)Newswise — Piscataway, NJ – Many viruses infecting humans including influenza virus, hepatitis C virus, West Nile virus, rabies and measles viruses contain a ribonucleic acid (RNA) genome. These viruses are dependent on RNA as genetic information and ...See all stories on this topic »

Old, diseased organs no barrier to donationHerald SunLast year, half the nation's 309 donors had been smokers, 14 had cancer, 20 had hepatitis B, two had hepatitis C, 29 had diabetes and 86 had high blood pressure. In Australia, hepatitis B and C, cancer and the arenavirus have been passed on through ...See all stories on this topic »

Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for ...MarketWatch (press release)In this trial, 66 patients with previously untreated genotype-1 hepatitis C virus (HCV) infection were treated with 12 weeks of ribavirin in combination with bavituximab or pegylated interferon alpha-2a. Bavituximab is a phosphatidylserine ...See all stories on this topic »